Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
65
Views
10
CrossRef citations to date
0
Altmetric
Review

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice

Nevena SkrozaDermatology Unit “Daniele Innocenzi”, Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, Fiorini Hospital, Polo Pontino, 04019 Terracina, Italy, [email protected]Correspondence[email protected]
,
Nicoletta BernardiniDermatology Unit “Daniele Innocenzi”, Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, Fiorini Hospital, Polo Pontino, 04019 Terracina, Italy, [email protected]
,
Ilaria ProiettiDermatology Unit “Daniele Innocenzi”, Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, Fiorini Hospital, Polo Pontino, 04019 Terracina, Italy, [email protected]
&
Concetta PotenzaDermatology Unit “Daniele Innocenzi”, Department of Medical-Surgical Sciences and Bio-Technologies, Sapienza University of Rome, Fiorini Hospital, Polo Pontino, 04019 Terracina, Italy, [email protected]
Pages 1879-1885 | Published online: 04 Oct 2018

Figures & data

Figure 1 Clinical aspects at baseline, during and after ingenol mebutate treatment in a 65-year-old man.

Figure 1 Clinical aspects at baseline, during and after ingenol mebutate treatment in a 65-year-old man.

Figure 2 Clinical aspects at baseline, during and after ingenol mebutate treatment in a 71-year-old woman.

Figure 2 Clinical aspects at baseline, during and after ingenol mebutate treatment in a 71-year-old woman.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.